CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleRevenue is $2.3B, above the global median of $548.88M
- PositionPrice-to-book is 0.72×, lower than 95% of its Medical Devices peers (median 2.9×)
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.06BUSDvs all stocks (USD)
Revenue (TTM)
2.30BUSDvs all stocks (USD)
Profit Margin
-47.97%vs Medical Devices peers
Beta
1.43xvs all stocks
52-Week Change
-38.83%vs all stocks
Market Capitalization
1.06BUSDvs all stocks (USD)
Enterprise Value
2.42BUSDvs all stocks (USD)
Forward P/E
5.00xvs Medical Devices peers
Price to Sales (TTM)
0.4635xvs Medical Devices peers
Price to Book (MRQ)
0.7207xvs Medical Devices peers
Enterprise to Revenue
1.05xvs Medical Devices peers
Enterprise to EBITDA
6.38xvs Medical Devices peers
Gross Margin
61.64%vs Medical Devices peers
Profit Margin
-47.97%vs Medical Devices peers
Operating Margin
4.18%vs Medical Devices peers
Return on Assets (TTM)
1.20%vs Medical Devices peers
Return on Equity (TTM)
-54.14%vs Medical Devices peers
Revenue (TTM)
2.30BUSDvs all stocks (USD)
Revenue per Share (TTM)
40.07USDUpdated Sep 27, 2026Quarterly Revenue Growth
3.20%vs Medical Devices peers
Gross Profit (TTM)
1.41BUSDvs all stocks (USD)
EBITDA (TTM)
369.35MUSDvs all stocks (USD)
Net Income (TTM)
-1.10BUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
3.23%vs Medical Devices peers
Operating Cash Flow (TTM)
270.10MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
185.94MUSDvs all stocks (USD)
Payout Ratio
0.00%vs Medical Devices peers
Minority Interest (Equity)
2.26MUSDFY2025 · Dec 31, 2025Revenue
2.25BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
902.79MUSDFY2025 · Dec 31, 2025Gross Profit
1.35BUSDFY2025 · Dec 31, 2025Operating Income
-18.87MUSDvs all stocks (USD)
Pre-tax Income
-1.16BUSDFY2025 · Dec 31, 2025Income Tax Expense
22.29MUSDFY2025 · Dec 31, 2025Net Income
-1.18BUSDFY2025 · Dec 31, 2025EBIT
-1.12BUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
275.14MUSDFY2025 · Dec 31, 2025Research & Development
120.33MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
1.07BUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
34.82MUSDFY2025 · Dec 31, 2025EPS (Basic)
-20.75USDFY2025 · Dec 31, 2025EPS (Diluted)
-20.75USDFY2025 · Dec 31, 2025Basic Shares Outstanding
57.07MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
57.07MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-1.18BUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
-820.00KUSDFY2025 · Dec 31, 2025Operating Cash Flow
-835.70MUSDFY2025 · Dec 31, 2025Free Cash Flow
-1.03BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
36.39MUSDFY2025 · Dec 31, 2025Income Tax Paid
18.38MUSDFY2025 · Dec 31, 2025Interest Paid
27.45MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-1.18BUSDFY2025 · Dec 31, 2025Depreciation & Amortization
294.38MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-2.23MUSDFY2025 · Dec 31, 2025Stock-based Compensation
32.92MUSDFY2025 · Dec 31, 2025Other Non-cash Items
7.38MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-10.75MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-1.14MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
27.35MUSDFY2025 · Dec 31, 2025Capital Expenditures
-197.38MUSDFY2025 · Dec 31, 2025Net Acquisitions
16.40MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-180.97MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
544.00MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-580.92MUSDFY2025 · Dec 31, 2025Other Financing Charges
-16.79MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-52.40MUSDFY2025 · Dec 31, 2025Shares Outstanding
57.67MSharesUpdated Sep 27, 2026Float Shares
52.76MSharesUpdated Sep 27, 2026Shares Short
9.48MSharesUpdated Sep 27, 2026Short Ratio
5.83daysvs all stocks
Short % of Shares Outstanding
19.60%vs all stocks
% Held by Insiders
1.64%vs all stocks
% Held by Institutions
125.12%vs all stocks
Total Cash (MRQ)
12.56MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.2180USDUpdated Sep 27, 2026Total Debt (MRQ)
1.37BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.9255xvs Medical Devices peers
Current Ratio (MRQ)
1.99xvs Medical Devices peers
Book Value per Share (MRQ)
25.61USDUpdated Sep 27, 2026Total Assets
3.83BUSDvs all stocks (USD)
Total Current Assets
1.21BUSDFY2025 · Dec 31, 2025Total Liabilities
2.34BUSDFY2025 · Dec 31, 2025Total Non-current Assets
2.63BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
1.74BUSDFY2025 · Dec 31, 2025Total Current Liabilities
598.47MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
36.39MUSDFY2025 · Dec 31, 2025Accounts Receivable
442.79MUSDFY2025 · Dec 31, 2025Inventory
584.38MUSDFY2025 · Dec 31, 2025Accounts Payable
187.53MUSDFY2025 · Dec 31, 2025Short-term Debt
59.74MUSDFY2025 · Dec 31, 2025Deferred Revenue
6.50MUSDFY2025 · Dec 31, 2025Other Current Liabilities
51.48MUSDFY2025 · Dec 31, 2025Long-term Debt
1.32BUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
424.57MUSDFY2025 · Dec 31, 2025Common Stock (Book)
57.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-1.47BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
1.49BUSDvs all stocks (USD)
52-Week Low
17.30USDUpdated Sep 27, 202652-Week High
34.28USDUpdated Sep 27, 202652-Week Change
-38.83%vs all stocks
Beta
1.43xvs all stocks
50-Day MA
24.09USDUpdated Sep 27, 2026200-Day MA
24.06USDUpdated Sep 27, 2026Avg 10-Day Volume
2.08MSharesUpdated Sep 27, 2026Avg 30-Day Volume
1.67MSharesUpdated Sep 27, 2026Diluted EPS (TTM)
-19.27USDUpdated Sep 27, 2026Other Income / Expense
-1.11BUSDFY2025 · Dec 31, 2025Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Price-to-book is 0.72×, lower than 95% of its Medical Devices peers (median 2.9×)Notable
Price-to-book: 0.72Industry median: 2.90Industry P5: 1.18Peers compared: 60.00
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.62Profit Margin: -0.48
Looks liquid, but the distress score says otherwiseNotable
Current Ratio: 1.99Altman Z-Score: -0.45
Financial Health
Altman Z-Score -0.45: distress zoneCritical
Altman Z-Score: -0.45
High earnings qualityNotable
Earnings Quality Score: 1.92
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Revenue is $2.3B, above the global median of $548.88MNotable
Revenue (USD): 2,296,602,880Global Median: 548,883,780.48
Levered free cash flow is $185.94M, above the global median of $18.73MNotable
Levered free cash flow (USD): 185,942,752Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Guangxi Wuzhou Zhongheng Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Guilin Sanjin Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Inkon Life Tech Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
MannKind Corporation
Tier 1ProductionApproval-Gated PipelineRule
Lifetech Scientific Corporation
Tier 1ProductionApproval-Gated PipelineRule
Xiangyu Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zylox-Tonbridge Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Kanion Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Star Lake Bioscience Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Anhui Hongyu Wuzhou Medica Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule